PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook

BackgroundProstate specific membrane antigen (PSMA) PET imaging has recently gained attention in glioblastoma (GBM) patients as a potential theranostic target for PSMA radioligand therapy. However, PSMA PET has not yet been established in a murine GBM model. Our goal was to investigate the potential...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maximilian A. Kirchner, Adrien Holzgreve, Matthias Brendel, Michael Orth, Viktoria C. Ruf, Katja Steiger, Dennis Pötter, Lukas Gold, Marcus Unterrainer, Lena M. Mittlmeier, Enio Barci, Roland E. Kälin, Rainer Glass, Simon Lindner, Lena Kaiser, Jessica Maas, Louisa von Baumgarten, Harun Ilhan, Claus Belka, Johannes Notni, Peter Bartenstein, Kirsten Lauber, Nathalie L. Albert
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-11-01
Col·lecció:	Frontiers in Oncology
Matèries:	Prostate specific membrane antigen (PSMA) 18F-PSMA-1007 PET glioblastoma GL261 preclinical mouse
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2021.774017/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!